Latest Commercialization News

4DMedical has won a crucial US Medicare reimbursement for its CT, VQ™ lung imaging software, paving the way for rapid adoption across American hospitals. This milestone follows FDA clearance and promises to transform lung diagnostics with safer, faster scans.

Brazilian Rare Earths Limited has obtained the final regulatory approval to operate its rare earth pilot plant in Brazil’s largest petrochemical complex, setting the stage for pilot operations in mid-2026.

Intelligent Monitoring Group has completed its $4.5 million acquisition of Western Advance, bolstering its presence in Western Australia's oil and gas security sector.

OM Holdings reported steady revenue of US$309.3 million in 1H 2025 despite a sharp EBITDA decline and net loss, while maintaining a strong cash position and advancing sustainability goals.

Cambium Bio has struck a licensing deal with Keke Medtech to commercialise its fibrin biologic in dental applications, unlocking new markets and non-dilutive funding.

Cauldron Energy has terminated its purchase agreement for river sand leases at Carnarvon and Derby, retaining the Onslow tenements with no further payments required, including cancellation of 2 million shares.

Emperor Energy has initiated a farm-in process to fund the Judith-2 appraisal well, aiming to unlock substantial gas reserves offshore Victoria and address tightening East Coast gas supply.

PolyNovo Limited stands to benefit from proposed U.S. Medicare changes that introduce a flat reimbursement rate for outpatient wound care skin substitutes, potentially reshaping the competitive landscape in favour of cost-effective, clinically proven products.

Carnegie Clean Energy is closing its Share Purchase Plan on 8 September, offering shareholders a discounted entry to fund key ocean energy projects. The capital raise aims to accelerate development in Europe, the US, and Australia.

4DMedical has bolstered its financial footing with a $6 million R&D tax incentive and a $10 million strategic investment, while its XV LVAS® technology gains clinical validation for predicting serious COPD treatment complications.

Race Oncology has activated its first clinical trial site in Hong Kong for the Phase 1 study of RC220 combined with doxorubicin in advanced solid tumours, marking a significant step in accelerating patient enrolment and broadening clinical data.

Rimfire Pacific Mining has identified three promising base metal drill targets near Broken Hill, expanding its exploration focus beyond cobalt. The company is exploring commercial options to unlock value from these discoveries amid a regional mining resurgence.